Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

KZR Kezar Life Sciences Inc

0,7759

0,006 (0,78%)

Nach Börsenschluss

Zuletzt aktualisiert: 22:30:00

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Kezar Life Sciences (NASDAQ:KZR)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Kezar Life Sciences Charts.

Kezar Life Sciences (NASDAQ:KZR)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Kezar Life Sciences Charts.

News Kezar Life Sciences Inc

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 9 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 9 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
Donnerstag 9 Mai 2024 (2 Wochen vor) • Business Wire

Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Montag 6 Mai 2024 (2 Wochen vor) • Business Wire

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Montag 8 April 2024 (1 Monat vor) • Business Wire

Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
Donnerstag 14 März 2024 (2 Monate vor) • Business Wire

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Freitag 8 März 2024 (2 Monate vor) • Business Wire

Kezar Life Sciences to Participate in the TD Cowen 44th Annual Health Care Conference
Mittwoch 28 Februar 2024 (3 Monate vor) • Business Wire

Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis
Dienstag 27 Februar 2024 (3 Monate vor) • Business Wire

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Mittwoch 17 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 9 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere Kezar Life Sciences Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen